A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling

Richard A. Klinghoffer, Jason Frazier, James Annis et al. · 2009

Read A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling by Richard A. Klinghoffer, Jason Frazier, James Annis et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006892.txt.

Description

Richard A. Klinghoffer and colleagues screened for genes that tune a major signaling pathway in PLOS ONE in 2009. The pathway centers on beta-catenin, kept low by a destruction complex. A kinase in that complex, GSK3, marks beta-catenin for disposal. The screen used lentiviruses to deliver genetic changes. It searched for modulators of beta-catenin and GSK3 signaling.

The screen identified dihydrofolate reductase, DHFR, as a modulator. DHFR is famous as a target of antifolate drugs. Finding it in this pathway was unexpected. The link suggests old drugs may influence Wnt signaling. It also adds a metabolic enzyme to a developmental pathway's control list.

Catalog record

CREATORRichard A. Klinghoffer, Jason Frazier, James Annis et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006892

Browse the full library · About the Tower of Babel